Collier, DA;
Monit, C;
Gupta, RK;
(2019)
The Impact of HIV-1 Drug Escape on the Global Treatment Landscape.
Cell Host & Microbe
, 26
(1)
pp. 48-60.
10.1016/j.chom.2019.06.010.
Preview |
Text
Collier Final_Reviers comments addressed_sumitted version Perspective on HIV drug resistance .pdf - Accepted Version Download (927kB) | Preview |
Abstract
The rising prevalence of HIV drug resistance (HIVDR) could threaten gains made in combating the HIV epidemic and compromise the 90-90-90 target proposed by United Nations Programme on HIV/AIDS (UNAIDS) to have achieved virological suppression in 90% of all persons receiving antiretroviral therapy (ART) by the year 2020. HIVDR has implications for the persistence of HIV, the selection of current and future ART drug regimens, and strategies of vaccine and cure development. Focusing on drug classes that are in clinical use, this Review critically summarizes what is known about the mechanisms the virus utilizes to escape drug control. Armed with this knowledge, strategies to limit the expansion of HIVDR are proposed.
| Type: | Article |
|---|---|
| Title: | The Impact of HIV-1 Drug Escape on the Global Treatment Landscape |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.chom.2019.06.010 |
| Publisher version: | https://doi.org/10.1016/j.chom.2019.06.010 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10083660 |
Archive Staff Only
 |
View Item |
